Akero Therapeutics, Inc. (AKRO)
Dec 9, 2025 - AKRO was delisted (reason: acquired by NVO)
54.65
0.00 (0.00%)
Inactive · Last trade price on Dec 8, 2025

Akero Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Akero Therapeutics stock had an average target of $73.56, with a low estimate of $54 and a high estimate of $109.

Price Target: $73.56 (+34.60%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$54$73.56n/a$109
Change-1.19%+34.60%n/a+99.45%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock from 11 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.79
from -3.75
EPS Next Year
-4.40
from -3.79
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
EPS
-2.52-2.89-2.87-2.89-3.75-3.79-4.40
No. Analysts
-----109

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-3.77-4.18
Avg-3.79-4.40
Low-3.86-4.90

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--